Apriori Bio
MA - CambridgeBiotechnology
Focus: Apriori Bio is an AI-driven biotech platform focused on viral variant identification with applications in oncology, operating from Cambridge, MA since 2020. The company is actively hiring across 90 open roles, indicating early-stage growth and expansion.
Profile data last refreshed 12h ago · AI intelligence enriched 1w ago
Open Jobs
106+62 this month
Hot — 93 jobs added in 30d
Net +62 (93 new, 31 removed). Aggressive expansion phase.
Should You Work at Apriori Bio?
AI assessmentApriori Bio suits technologists and computational researchers seeking high-impact AI roles in drug discovery, but offers limited near-term clinical validation or public market exit signal.
Why Work Here
- Join a computational biology pioneer with proprietary AI technology for viral variant identification—a cutting-edge intersection of machine learning and drug discovery.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Apriori Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.